Latest News - Pharm Tech Europe

Six-step plan for improved FDA enforcement

14 August 2009

FDA Commissioner Margaret Hamburg has outlined six initial steps designed to improve the effectiveness and timeliness of FDA?s regulatory and enforcement system.

Green manufacturing with marine microbes

14 August 2009

Manufacturing methods for new drugs could be made greener and more efficient with the help of marine microbes.

Step carefully into foreign affairs

14 August 2009
By:Jim Miller

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

FDA guidance on monitoring at-risk melamine contamination

14 August 2009

The FDA has released its Guidance for Industry titled Pharmaceutical Components at Risk for Melamine Contamination.

GSK buys rights to staph infection vaccine

14 August 2009

GlaxoSmithKline (GSK) has signed an agreement to acquire US-based Nabi Biopharmaceuticals' PentaStaph programme, which will provide the company with a five component vaccine candidate for Pentavalent S. aureus.

Antipsychotic drugs dominate

14 August 2009

There is a considerable commercial opportunity for developers of antipsychotic drugs, according to market analysts Datamonitor, which claims that this class of drugs dominates the US market and boasted a global value of approximately $22 billion in 2008.

BIO asks Supreme Court to overturn Bilski

13 August 2009

The Biotechnology Industry Organization (BIO) has filed an amicus brief asking the US Supreme Court to overturn Bilski versus Doll, a decision of the US Court of Appeals for the Federal Circuit.

Freeze drying centre of excellence unveiled

07 August 2009

Reig Jofre has revealed further details about its Barcelona (Spain) based Centre of Excellence in the Freeze Drying Process — a project that represents an investment of approximately 12 million euro.

Pfizer Vs. Nigeria's Kano State case comes to a close

07 August 2009

An agreement has been reached between Pfizer and Nigeria's Kano State government following the long-running Trovan trial, which stems from the accusation that Pfizer illegally tested the antibiotic Trovan (trovafloxacin) on children in 1996 during a meningitis outbreak.

12 3 4 5 6 7 8 9 10 11 12

Advertisers

Request our 2009 Media Kit

Boost your marketing campaigns